Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes (T1-DISCO)

Primary Objective

The proposed pilot trial seeks to establish the impact of GLP-1RA as an adjunctive cardiorenal therapy in optimally managed T1D, to improve cardiovascular, kidney and metabolic function in young adults with T1D.

Is This Study For You?

Let's Get Started!




Anschutz Health and Wellness
Barbara Davis Center
Brain Imaging Center (BIC)
CTRC Inpatient
Outpatient CTRC
University of Colorado Hospital

Principal Investigator
Photograph of Petter Bjornstad

Petter Bjornstad

Study ID

Protocol Number: 22-0794

More information available at ClinicalTrials.gov: NCT05819138

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers